4.6 Review

From gatekeepers to providers: regulation of immune functions by cancer-associated fibroblasts

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

CCL18 signaling from tumor-associated macrophages activates fibroblasts to adopt a chemoresistance-inducing phenotype

Wenfeng Zeng et al.

Summary: This study reveals that CCL18 secreted by TAMs activates a CD10(+)GPR77(+) CAF phenotype in NBFs, leading to the enrichment of CSCs and chemoresistance in breast cancer cells. Mechanistically, CCL18 activates NF-kappa B signaling via PITPNM3 and enhances IL-6 and IL-8 production. Targeting CCL18 with anti-CCL18 antibody inhibits the formation of CD10(+)GPR77(+) CAFs and restores chemosensitivity, effectively controlling tumors.

ONCOGENE (2023)

Review Oncology

Innate lymphoid cells: potential targets for cancer therapeutics

Chun Ki Ng et al.

Summary: Innate lymphoid cells (ILCs) are a group of immune cells that can respond rapidly to changing microenvironmental cues. They can either protect against tumor development or promote tumor progression and resistance to immunotherapy. This review discusses the regulation of ILCs and the potential for using their functional plasticity to develop therapeutic strategies to enhance immune responses and improve patient outcomes.

TRENDS IN CANCER (2023)

Article Hematology

Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myeloma

Reona Sakemura et al.

Summary: This study investigated the pivotal clinical trials of B-cell maturation antigen-targeted chimeric antigen receptor T (CART)-cell therapy in patients with relapsed/refractory multiple myeloma (MM). The study found that durable remissions continue to be low and the main mechanism of resistance is loss of CART cells and inhibition by the tumor microenvironment (TME). Additionally, the study showed that cancer-associated fibroblasts (CAFs) inhibit CART-cell antitumor activity and promote MM progression. The study also proposed a novel strategy of dual targeting both malignant plasma cells and the CAFs within the TME to overcome resistance to CART-cell therapy in MM.

BLOOD (2022)

Article Oncology

Crosstalk between cancer-associated fibroblasts and immune cells in peritoneal metastasis: inhibition in the migration of M2 macrophages and mast cells by Tranilast

Yusuke Nakamura et al.

Summary: By suppressing cancer-associated fibroblasts (CAFs), Tranilast improved the immunosuppressive microenvironment in a mouse PM model and showed potential as a candidate drug for PM treatment.

GASTRIC CANCER (2022)

Article Immunology

Lung tumor MHCII immunity depends on in situ antigen presentation by fibroblasts

Dimitra Kerdidani et al.

Summary: This study identifies a subset of antigen-presenting fibroblasts (apCAFs) in human lung non-small cell carcinomas that actively promote CD4 T cell immunity by direct activation and rescue from apoptosis. The presence of these apCAFs suggests that in situ MHCII antigen presentation may be crucial for cancer immunotherapies.

JOURNAL OF EXPERIMENTAL MEDICINE (2022)

Article Gastroenterology & Hepatology

Targeting cancer-associated fibroblast-secreted WNT2 restores dendritic cell-mediated antitumour immunity

Tu-Xiong Huang et al.

Summary: Solid tumours have poor response to ICI therapies due to the immunosuppressive TME, where CAFs play a key role in negatively regulating antitumor T-cell responses. Targeting WNT2 secreted by CAFs could enhance ICI efficacy and serve as a new approach for anticancer immunotherapy.
Article Oncology

Landscape of cancer-associated fibroblasts identifies the secreted biglycan as a protumor and immunosuppressive factor in triple-negative breast cancer

Shaoquan Zheng et al.

Summary: This study reveals the important role of cancer-associated fibroblasts (CAFs) in TNBC and their correlation with tumor progression and the tumor microenvironment. The researchers also identify biglycan (BGN), a soluble secreted protein, as an upregulated marker in CAFs and suggest its potential as a prognostic marker and therapeutic target in TNBC.

ONCOIMMUNOLOGY (2022)

Article Oncology

Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer

Huocong Huang et al.

Summary: Recent studies have identified a unique population of cancer-associated fibroblasts (apCAFs) derived from mesothelial cells, which play a critical role in pancreatic cancer progression. These apCAFs directly induce naive CD4(+) T cells to differentiate into regulatory T cells (Tregs) in an antigen-specific manner.

CANCER CELL (2022)

Article Immunology

CD4+ T helper 2 cells suppress breast cancer by inducing terminal differentiation

Margherita Boieri et al.

Summary: This study demonstrates the important role of CD4(+) Th2 cells in immunity against breast cancer by forcing the cancer cells to terminally differentiate. Th2 cells directly block breast carcinogenesis by secreting specific cytokine signals, transforming high-grade breast tumors into low-grade, fibrocystic-like structures.

JOURNAL OF EXPERIMENTAL MEDICINE (2022)

Article Oncology

Mesenchymal Lineage Heterogeneity Underlies Nonredundant Functions of Pancreatic Cancer-Associated Fibroblasts

Erin J. Helms et al.

Summary: This study reveals the origins and functions of distinct cancer-associated fibroblast (CAF) subtypes in pancreatic ductal adenocarcinoma (PDAC). It shows that the abundant and transcriptionally diverse CAF population in PDAC arises from pancreatic stellate cells (PSC), but only a minor subset is derived from PSCs. These PSC-derived CAFs have unique functions in shaping the PDAC microenvironment.

CANCER DISCOVERY (2022)

Article Multidisciplinary Sciences

Single-cell and spatial analysis reveal interaction of FAP+ fibroblasts and SPP1+ macrophages in colorectal cancer

Jingjing Qi et al.

Summary: This study provides insights into the interaction between FAP(+) fibroblasts and SPP1(+) macrophages in colorectal cancer, suggesting a potential therapeutic strategy to improve immunotherapy by disrupting this interaction.

NATURE COMMUNICATIONS (2022)

Article Oncology

Identification of Functional Heterogeneity of Carcinoma-Associated Fibroblasts with Distinct IL6-Mediated Therapy Resistance in Pancreatic Cancer

Kathleen M. McAndrews et al.

Summary: The study identifies two distinct populations of fibroblasts with opposing roles in the progression and immune landscape of PDAC. Fibroblasts play diverse functions in regulating cancer-associated pathways and accumulation of regulatory T cells, impacting therapeutic efficacy in PDAC treatment. This finding reveals the functional heterogeneity of CAFs in PDAC progression, with significant implications for therapy response.

CANCER DISCOVERY (2022)

Article Oncology

Lipid-Associated Macrophages Are Induced by Cancer-Associated Fibroblasts and Mediate Immune Suppression in Breast Cancer

Eleonora Timperi et al.

Summary: This study identifies a novel lipid-associated macrophage subpopulation with immune suppressive functions and provides new leads for therapeutic interventions in triple-negative breast cancer.

CANCER RESEARCH (2022)

Article Oncology

Cancer-Associated Fibroblasts Suppress CD8+ T-cell Infiltration and Confer Resistance to Immune-Checkpoint Blockade

Liam Jenkins et al.

Summary: This study reveals that cancer-associated fibroblasts (CAF) can contribute to resistance to immune-checkpoint blockade therapy in breast cancer patients. High abundance of CAF is associated with an immunologically cold tumor microenvironment and decreased infiltration of CD8+ T cells. Additionally, the deletion of the CAF receptor Endo180 increases the infiltration of CD8+ T cells and enhances the sensitivity to immune-checkpoint blockade therapy.

CANCER RESEARCH (2022)

Editorial Material Cell Biology

Advancing beyond the twists and turns of T cell exhaustion in cancer

Verena van der Heide et al.

Summary: Chronic antigen stimulation leads to T cell exhaustion, which is further exacerbated by nutrient restrictions and other suppressive factors in the tumor microenvironment. Understanding the heterogeneity and dynamics of exhausted CD8 T cells will guide the development of novel therapies to modulate T cell differentiation for more effective anti-tumor responses.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Article Immunology

Lung fibroblasts facilitate pre-metastatic niche formation by remodeling the local immune microenvironment

Zheng Gong et al.

Summary: This study identified a population of fibroblasts that express COX-2 and remodel the lung immune microenvironment, promoting breast cancer metastasis. Genetic ablation of COX-2 in fibroblasts reversed the immune-suppressive phenotypes and improved the anti-metastatic activity of DC-based therapy and PD-1 blockade.

IMMUNITY (2022)

Article Oncology

Global DNA Methylation Analysis of Cancer-Associated Fibroblasts Reveals Extensive Epigenetic Rewiring Linked with RUNX1 Upregulation in Breast Cancer Stroma

Coral Halperin et al.

Summary: The first genome-wide map of DNA methylation in breast cancer-associated fibroblasts reveals a previously unknown facet of the dynamic plasticity of the stroma.

CANCER RESEARCH (2022)

Article Multidisciplinary Sciences

LRRC15+ myofibroblasts dictate the stromal setpoint to suppress tumour immunity

Akshay T. Krishnamurty et al.

Summary: The study reveals the crucial role of TGF beta-dependent LRRC15(+) CAFs in tumor growth, as well as their direct impact on CD8(+) T cell function and responsiveness to checkpoint blockade.

NATURE (2022)

Article Multidisciplinary Sciences

Chemotherapy-induced complement signaling modulates immunosuppression and metastatic relapse in breast cancer

Lea Monteran et al.

Summary: This study found that systemic treatment with doxorubicin following resection of triple-negative breast tumors induces the expression of complement factors in lung fibroblasts and modulates an immunosuppressive metastatic niche, thus promoting lung metastasis. Targeting complement signaling with pharmacological treatment can alleviate immune dysregulation and reduce lung metastasis.

NATURE COMMUNICATIONS (2022)

Article Multidisciplinary Sciences

BRCA mutational status shapes the stromal microenvironment of pancreatic cancer linking clusterin expression in cancer associated fibroblasts with HSF1 signaling

Lee Shaashua et al.

Summary: Tumors are initiated by mutations in cancer cells and progress through interactions with non-malignant cells of the tumor microenvironment. This study examines how different mutations in cancer cells affect the transcriptional rewiring of cancer-associated fibroblasts (CAFs) in pancreatic cancer. The researchers find that BRCA mutations lead to an increase in a specific subset of immune-regulatory CAFs, mediated by activation of heat-shock factor 1.

NATURE COMMUNICATIONS (2022)

Article Oncology

Spatial Positioning and Matrix Programs of Cancer-Associated Fibroblasts Promote T-cell Exclusion in Human Lung Tumor

John A. Grout et al.

Summary: This study identifies two populations of cancer-associated fibroblasts (CAF) in lung tumors that are associated with T-cell exclusion. These populations orchestrate a specific structural tissue organization and produce distinct matrix molecules. The findings highlight the importance of targeting these CAF populations to increase immunotherapy efficacy in patients with T cell-excluded tumors.

CANCER DISCOVERY (2022)

Review Oncology

Cancer-associated fibroblasts in the single-cell era

Dor Lavie et al.

Summary: Cancer-associated fibroblasts (CAFs) play a central role in the microenvironment of solid tumors, and recent advances in single-cell technologies have provided insights into their complexity and heterogeneity. Understanding the subsets and functions of CAFs can potentially lead to better therapeutic strategies for cancer.

NATURE CANCER (2022)

Article Gastroenterology & Hepatology

Extrinsic KRAS Signaling Shapes the Pancreatic Microenvironment Through Fibroblast Reprogramming

Ashley Velez-Delgado et al.

Summary: This study reveals that non-cell autonomous oncogenic KRAS signaling can reprogram pancreatic fibroblasts, leading to an inflammatory response and affecting the tumor microenvironment, thereby promoting tumor development.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2022)

Review Oncology

Cytotoxic CD8+T cells in cancer and cancer immunotherapy

Hans Raskov et al.

Summary: The functions and interactions between the innate and adaptive immune systems play a crucial role in anticancer immunity. Cytotoxic T cells with CD8 as the most effective effectors in the anticancer immune response form the basis of successful cancer immunotherapies. Advancements in genetically modified or synthetic receptors on cytotoxic T cells are being developed for future cancer treatment. Combinatory regimens may optimize treatment effects and reduce adverse events in cancer therapy.

BRITISH JOURNAL OF CANCER (2021)

Article Oncology

Stromal fibroblasts shape the myeloid phenotype in normal colon and colorectal cancer and induce CD163 and CCL2 expression in macrophages

Mira Stadler et al.

Summary: Colorectal cancer is influenced by the tumor microenvironment, where cancer-associated fibroblasts and tumor-associated macrophages play crucial roles. The molecular crosstalk between tumor cells, fibroblasts, and macrophages affects monocyte recruitment and their differentiation into immunosuppressive macrophages. Cytokine profiling shows that fibroblasts induce specific cytokine secretion in co-culture with macrophages, contributing to tumor cell invasion.

CANCER LETTERS (2021)

Article Oncology

Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma

Qitai Zhao et al.

Summary: This study identified the correlation between monocytic myeloid-derived suppressor cells (M-MDSCs) and cisplatin resistance in patients with esophageal squamous cell carcinoma (ESCC). Furthermore, it was found that cancer-associated fibroblasts (CAFs) promoted the differentiation of monocytes into M-MDSCs through the secretion of interleukin-6 (IL-6) and exosome-packed microRNA-21 (miR-21), activating the STAT3 signaling pathway. The study highlights the potential of targeting the STAT3 signaling pathway as a strategy to reverse drug resistance in ESCC patients with high infiltration of CAFs and myeloid cells.

CANCER LETTERS (2021)

Article Chemistry, Physical

Tumour-associated macrophages drive stromal cell-dependent collagen crosslinking and stiffening to promote breast cancer aggression

Ori Maller et al.

Summary: Stromal stiffening in malignant tumours is associated with poor treatment outcomes and increased tumour aggression. Identifying factors that regulate stromal stiffening could lead to biomarkers for patient stratification and interventions to improve outcomes. Experimental studies have shown that therapeutic targeting of tumour-associated macrophages and collagen crosslinking enzymes can reduce metastasis and stromal stiffening in aggressive breast cancer subtypes with stiff stroma. Additionally, the expression of lysyl hydroxylase 2 in the stroma has been linked to disease-specific mortality in breast cancer patients, indicating its potential as a stromal biomarker.

NATURE MATERIALS (2021)

Article Oncology

Type I collagen deletion in αSMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer

Yang Chen et al.

Summary: The stromal desmoplastic reaction in pancreatic ductal adenocarcinoma involves significant accumulation of type I collagen (Col1). Deletion of Col1 specifically in myofibroblasts accelerates PDAC progression by increasing Cxcl5 expression in cancer cells and promoting recruitment of myeloid-derived suppressor cells. Targeting CXCR2 and CCR2 may help restrain accelerated PDAC progression in the absence of stromal Col1.

CANCER CELL (2021)

Article Oncology

Cancer-Associated Fibroblasts Promote Aggressive Gastric Cancer Phenotypes via Heat Shock Factor 1-Mediated Secretion of Extracellular Vesicles

Nil Grunberg et al.

Summary: This study used RNA sequencing of CAFs from gastric cancer patients to identify a stromal gene signature associated with aggressive gastric cancer, with HSF1 playing a key regulatory role in this signature. HSF1 upregulates inhibin subunit beta A and thrombospondin 2, which are secreted in CAF-derived extracellular vesicles to promote cancer progression.

CANCER RESEARCH (2021)

Review Biochemistry & Molecular Biology

Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives

Xiaoqi Mao et al.

Summary: CAFs, as a crucial component of TME, play significant roles in promoting tumor growth, invasion, and metastasis. The interaction between CAFs and tumor cells, as well as immune cells in TIME, is critical for tumor progression.

MOLECULAR CANCER (2021)

Article Gastroenterology & Hepatology

Cancer-Associated Fibroblast-Mediated Cellular Crosstalk Supports Hepatocellular Carcinoma Progression

Mengjia Song et al.

Summary: This study revealed a cytokine-mediated cellular crosstalk and clinical network involving the CLCF1-CXCL6/TGF-beta axis, which regulates the positive feedback loop among CAFs, tumor stemness, and TANs, HCC progression, and patient prognosis. The up-regulation of the CLCF1-CXCL6/TGF-beta axis in clinical samples showed a correlation with increased cancer stem cells, N2-polarized TANs, tumor stage, and poor prognosis. This suggests the CLCF1 cascade could be a potential prognostic biomarker and targeting CLCF1/ ciliary neurotrophic factor receptor or ERK1/2 signaling could provide an effective therapeutic target for patients with HCC.

HEPATOLOGY (2021)

Article Oncology

Relationship between podoplanin-expressing cancer-associated fibroblasts and the immune microenvironment of early lung squamous cell carcinoma

Jun Suzuki et al.

Summary: PDPN+ CAFs in lung squamous cell carcinoma showed higher TGFB1 expression and were associated with infiltration of CD204(+) TAMs, indicating that PDPN+ CAFs were related to the immunosuppressive tumor microenvironment.

LUNG CANCER (2021)

Article Multidisciplinary Sciences

Stromal-driven and Amyloid β-dependent induction of neutrophil extracellular traps modulates tumor growth

Hafsa Munir et al.

Summary: The study reveals that cancer-associated fibroblasts (CAF) induce the formation of neutrophil extracellular traps (NET) within tumors and systemically in the blood and bone marrow. These tumor-induced NETs are driven by a ROS-mediated pathway dependent on CAF-derived Amyloid beta peptide. Inhibition of NETosis skews neutrophils to an anti-tumor phenotype, while t-NETs enhance CAF activation.

NATURE COMMUNICATIONS (2021)

Review Immunology

Fibroblast-macrophage reciprocal interactions in health, fibrosis, and cancer

Matthew B. Buechler et al.

Summary: Fibroblasts and macrophages are able to communicate directly in tissues, influencing the microenvironment and disease outcomes. Their interactions play a significant role in health, fibrosis, and cancer, with effects influenced by tissue and context, as well as cell origin and state.

IMMUNITY (2021)

Letter Biochemistry & Molecular Biology

Cancer-associated fibroblast-derived gene signatures determine prognosis in colon cancer patients

Mercedes Herrera et al.

MOLECULAR CANCER (2021)

Article Multidisciplinary Sciences

Cross-tissue organization of the fibroblast lineage

Matthew B. Buechler et al.

Summary: Recent studies have identified fibroblast heterogeneity in different tissues, and constructed fibroblast atlases based on single-cell transcriptomic data to reveal universal and activated transcriptional subtypes in healthy and diseased states.

NATURE (2021)

Article Oncology

Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity

Colin Hutton et al.

Summary: This study used mass cytometry to analyze the stromal composition in murine tissues and tumors, revealing extensive stromal heterogeneity and coordinated relationships between mesenchymal and immune cell subsets in pancreatic ductal adenocarcinoma. The research identified two stable and functionally distinct pancreatic fibroblast lineages marked by CD105 expression, with CD105-positive fibroblasts promoting tumor growth and CD105-negative fibroblasts suppressing tumors, dependent on adaptive immunity. These findings highlight the importance of mesenchymal and immune cell interactions in restricting tumor growth.

CANCER CELL (2021)

Article Oncology

Cancer-associated fibroblast-induced M2-polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor-1 pathway

Shuhai Chen et al.

Summary: This study found that in hepatocellular carcinoma, CAFs promote M2 polarization of TAMs and induce secretion of PAI-1 via CXCL12, enhancing the malignant behavior of HCC cells.

INTERNATIONAL JOURNAL OF ONCOLOGY (2021)

Review Immunology

Lymph node fibroblastic reticular cells steer immune responses

Lushen Li et al.

Summary: This article summarizes the anatomical, phenotypic, and functional characteristics of FRC subsets in lymph nodes, discusses the changes in FRC during inflammation, and highlights the crosstalk between FRCs and immune cells. It emphasizes the state-of-the-art FRC-based therapeutic approaches for maintaining physiological homeostasis, steering protective immunity, inducing transplantation tolerance, and treating diverse immune-related diseases.

TRENDS IN IMMUNOLOGY (2021)

Article Cell Biology

Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts

Anthony B. Rodriguez et al.

Summary: The study reveals that the development of tumor-associated tertiary lymphoid structures (TA-TLS) is orchestrated by cancer-associated fibroblasts (CAF) with characteristics of lymphoid tissue organizer cells, mediated by CD8 T cells and CXCL13-mediated recruitment of B cells. The presence and size of TA-TLS are correlated with reduced tumor size and overall response to checkpoint immunotherapy, providing a potential platform for cancer immunotherapy strategy.

CELL REPORTS (2021)

Article Immunology

Ionizing Radiation Curtails Immunosuppressive Effects From Cancer-Associated Fibroblasts on Dendritic Cells

Rodrigo Berzaghi et al.

Summary: CAFs actively participate in tumor development and impact treatment responses by promoting an immunosuppressive tumor microenvironment. This study demonstrates that CAFs interfere with DC immune functions, and suggests that certain radiation regimens may reverse CAF-mediated immunosuppressive effects.

FRONTIERS IN IMMUNOLOGY (2021)

Article Cell Biology

Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response

Yu Wang et al.

Summary: The study investigated the heterogeneity among PDAC patients in terms of CAFs, ductal cancer cells, and immune cells, revealing differences between dense-type and loose-type PDAC. A novel subtype of CAFs, meCAFs, was discovered in loose-type PDAC, playing a critical role in disease progression and response to immunotherapy. This finding highlights the importance of considering intertumoral heterogeneity in PDAC treatment strategies.

CELL DISCOVERY (2021)

Review Oncology

CAFs Interacting With TAMs in Tumor Microenvironment to Enhance Tumorigenesis and Immune Evasion

Gurcan Gunaydin

Summary: CAFs and TAMs are crucial players in the tumor microenvironment, playing key roles in tumor growth and progression. They have intricate interactions with each other and with tumor cells, impacting tumor progression and immune evasion. Understanding these interactions may lead to the development of novel therapeutic targets for cancer.

FRONTIERS IN ONCOLOGY (2021)

Article Medicine, Research & Experimental

Tumor restriction by type I collagen opposes tumor- promoting effects of cancer-associated fibroblasts

Sonakshi Bhattacharjee et al.

Summary: This study reveals that cancer-associated fibroblasts (CAF) promote tumor growth by interacting with tumor cells through the secretion of different mediators. However, the overall tumor-promoting effects of CAF can be opposed by mechanical restriction from type I collagen. Therapeutic targeting of tumor-promoting CAF mediators while preserving type I collagen may shift the balance from tumor promotion to tumor restriction.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Oncology

Netrin G1 Promotes Pancreatic Tumorigenesis through Cancer-Associated Fibroblast-Driven Nutritional Support and Immunosuppression

Ralph Francescone et al.

Summary: The study identified Netrin G1 as a promoter of PDAC tumorigenesis through its effects on CAFs and metabolism. Inhibiting NetG1 showed potential in limiting tumor growth, indicating it as a possible target for PDAC treatment. The findings also highlighted the interplay between fibroblasts, metabolism, and immune response in pancreatic cancer.

CANCER DISCOVERY (2021)

Review Oncology

In search of definitions: Cancer-associated fibroblasts and their markers

Martin Nurmik et al.

INTERNATIONAL JOURNAL OF CANCER (2020)

Article Biochemical Research Methods

NicheNet: modeling intercellular communication by linking ligands to target genes

Robin Browaeys et al.

NATURE METHODS (2020)

Review Immunology

The fibroblastic T cell niche in lymphoid tissues

Anne L. Fletcher et al.

CURRENT OPINION IN IMMUNOLOGY (2020)

Article Biochemistry & Molecular Biology

Stromal cell diversity associated with immune evasion in human triple-negative breast cancer

Sunny Z. Wu et al.

EMBO JOURNAL (2020)

Article Oncology

A framework for advancing our understanding of cancer-associated fibroblasts

Erik Sahai et al.

NATURE REVIEWS CANCER (2020)

Review Immunology

Dendritic cells in cancer immunology and immunotherapy

Stefanie K. Wculek et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Article Biochemistry & Molecular Biology

Resident Macrophages Cloak Tissue Microlesions to Prevent Neutrophil-Driven Inflammatory Damage

Stefan Uderhardt et al.

Review Immunology

Neutrophil Diversity in Health and Disease

Carlos Silvestre-Roig et al.

TRENDS IN IMMUNOLOGY (2019)

Review Oncology

Cancer immunoediting and resistance to T cell-based immunotherapy

Jake S. O'Donnell et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2019)

Article Multidisciplinary Sciences

Dickkopf-3 links HSF1 and YAP/TAZ signalling to control aggressive behaviours in cancer-associated fibroblasts

Nicola Ferrari et al.

NATURE COMMUNICATIONS (2019)

Article Biochemistry & Molecular Biology

Circuit Design Features of a Stable Two-Cell System

Xu Zhou et al.

Review Immunology

CD4 Helper and CD8 Cytotoxic T Cell Differentiation

Ichiro Taniuchi

ANNUAL REVIEW OF IMMUNOLOGY, VOL 36 (2018)

Article Biochemistry & Molecular Biology

Phenotype molding of stromal cells in the lung tumor microenvironment

Diether Lambrechts et al.

NATURE MEDICINE (2018)

Editorial Material Immunology

Dual Transforming Growth Factor-β and Programmed Death-1 Blockade: A Strategy for Immune-Excluded Tumors?

Claire Vanpouille-Box et al.

TRENDS IN IMMUNOLOGY (2018)

Article Multidisciplinary Sciences

Cancer-associated fibroblasts induce antigen-specific deletion of CD8+ T Cells to protect tumour cells

Matthew A. Lakins et al.

NATURE COMMUNICATIONS (2018)

Review Immunology

Alteration of the Antitumor immune Response by Cancer-Associated Fibroblasts

Linda Ziani et al.

FRONTIERS IN IMMUNOLOGY (2018)

Article Multidisciplinary Sciences

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells

Sanjeev Mariathasan et al.

NATURE (2018)

Article Immunology

Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer

Daniel Ohlund et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2017)

Article Biochemistry & Molecular Biology

KLF4-dependent perivascular cell plasticity mediates pre-metastatic niche formation and metastasis

Meera Murgai et al.

NATURE MEDICINE (2017)

Review Pharmacology & Pharmacy

Mast cell and eosinophil surface receptors as targets for anti-allergic therapy

Roopesh Singh Gangwar et al.

PHARMACOLOGY & THERAPEUTICS (2017)

Article Oncology

Myeloid-Derived Suppressor Cells

Dmitry I. Gabrilovich

CANCER IMMUNOLOGY RESEARCH (2017)

Review Immunology

Are Mast Cells MASTers in Cancer?

Gilda Varricchi et al.

FRONTIERS IN IMMUNOLOGY (2017)

Article Biochemistry & Molecular Biology

Interferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity

Abigail E. Overacre-Delgoffe et al.

Review Cell Biology

Carcinoma-associated fibroblasts: orchestrating the composition of malignancy

Philippe Gascard et al.

GENES & DEVELOPMENT (2016)

Article Biochemistry & Molecular Biology

Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy

Hong Jiang et al.

NATURE MEDICINE (2016)

Review Oncology

The biology and function of fibroblasts in cancer

Raghu Kalluri

NATURE REVIEWS CANCER (2016)

Article Multidisciplinary Sciences

Identification and isolation of a dermal lineage with intrinsic fibrogenic potential

Yuval Rinkevich et al.

SCIENCE (2015)

Review Multidisciplinary Sciences

T cell exclusion, immune privilege, and the tumor microenvironment

Johanna A. Joyce et al.

SCIENCE (2015)

Article Biochemistry & Molecular Biology

The Reprogramming of Tumor Stroma by HSF1 Is a Potent Enabler of Malignancy

Ruth Scherz-Shouval et al.

Article Multidisciplinary Sciences

Distinct fibroblast lineages determine dermal architecture in skin development and repair

Ryan R. Driskell et al.

NATURE (2013)

Article Multidisciplinary Sciences

Targeting CXCL12 from FAP-expressing carcinomaassociated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer

Christine Feig et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Genetics & Heredity

Distinct epigenetic changes in the stromal cells of breast cancers

M Hu et al.

NATURE GENETICS (2005)